Moneycontrol boarder Somesh Mahajan from Delhi enquired how will one rate the current earnings season so far and also the top two outperformers among large cap and midcap stocks.
UR Bhat, MD, Dalton Capital Advisors says the quarterly result for December has been quite bad especially the public sector bank situation is extremely poor. There have been no great positive surprises except on the pharma side. Pharma has done well, IT has done reasonably well but other than that there is nothing much to comment on. But in the large cap space there are at least some stocks that have come in the investment range and provided everything else falls in place, I think these are stocks one could start buying a bit not going the hog but nibbling away, says Bhat.
”FMCG has not been a great performer but otherwise especially the cyclicals have been quite disappointing and that would probably continue till a new government is in place,” he adds.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
